SLNO Q1 2018 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$3M

Net Income

-$4M

EPS (Diluted)

$-2.88

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$341,000

Balance Sheet

Total Assets

$36M

Total Liabilities

$13M

Stockholders' Equity

$23M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$265,000	-100.0%
Gross Profit	$0	$56,000	-100.0%
Operating Income	-$3M	-$2M	-57.2%
Net Income	-$4M	-$3M	-30.1%